These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 975068

  • 1. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells.
    Papahadjopoulos D, Poste G, Vail WJ, Biedler JL.
    Cancer Res; 1976 Sep; 36(9 pt.1):2988-94. PubMed ID: 975068
    [Abstract] [Full Text] [Related]

  • 2. The relationship among transport, intracellular binding, and inhibition of RNA synthesis by actinomycin D in Ehrlich ascites tumor cells in vitro.
    Bowen D, Goldman ID.
    Cancer Res; 1975 Nov; 35(11 Pt 1):3054-60. PubMed ID: 1182700
    [Abstract] [Full Text] [Related]

  • 3. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
    Inaba M, Johnson RK.
    Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma membrane proteins and glycoproteins from Chinese hamster cells sensitive and resistant to actinomycin D.
    Peterson RH, Biedler JL.
    J Supramol Struct; 1978 Dec; 9(3):289-98. PubMed ID: 748679
    [Abstract] [Full Text] [Related]

  • 6. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY, Bor AM, Chan PK.
    Cancer Res; 1990 Sep 15; 50(18):5987-91. PubMed ID: 1697505
    [Abstract] [Full Text] [Related]

  • 7. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB, Rittmann-Grauer L, O'Brien JP, Safa AR.
    Cancer Res; 1989 Jun 15; 49(12):3209-14. PubMed ID: 2566379
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
    Sato S, Watanabe Y, Okamura K, Hamanaka R, Mori T, Kohno K, Kuwano M.
    Anticancer Drug Des; 1989 Aug 15; 4(2):125-35. PubMed ID: 2803461
    [Abstract] [Full Text] [Related]

  • 10. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May 15; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 11. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
    Stevens J, Stevens YW.
    Cancer Res; 1975 Aug 15; 35(8):2145-53. PubMed ID: 1149029
    [Abstract] [Full Text] [Related]

  • 12. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, Li LH, Bhuyan BK.
    Cancer Res; 1990 Apr 15; 50(8):2485-92. PubMed ID: 2317831
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversal of multidrug resistance by lipophilic drugs.
    Hofsli E, Nissen-Meyer J.
    Cancer Res; 1990 Jul 01; 50(13):3997-4002. PubMed ID: 2354448
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cellular resistance to DNA-topoisomerase II inhibitors].
    Jacquemin-Sablon A, Bojanowski K, Casabianca-Pignède MR, Crémier S, Delaporte C, Khelifa T, Markovits J, René B, Saucier JM, Larsen AK.
    Bull Cancer; 1994 May 01; 81(5):381-5. PubMed ID: 7749214
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the effects of lucanthone (miracil D) and actinomycin D on the Chinese hamster cells grown in cultures.
    Epifanova OI, Makarova GF, Abuladze MK.
    J Cell Physiol; 1975 Oct 01; 86(2 Pt 1):261-8. PubMed ID: 1194365
    [Abstract] [Full Text] [Related]

  • 19. [Effect of actinomycin D on RNA synthesis in a stationary culture of Chinese hamster cells stimulated to proliferate].
    Zosimovskaia AI, Terskikh VV.
    Tsitologiia; 1975 Jul 01; 17(7):791-6. PubMed ID: 1172310
    [Abstract] [Full Text] [Related]

  • 20. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.
    Rittmann-Grauer LS, Yong MA, Sanders V, Mackensen DG.
    Cancer Res; 1992 Apr 01; 52(7):1810-6. PubMed ID: 1348013
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.